GenBioPro Sues FDA To Keep Generic Mifepristone Available; Supreme Court Delays Its Decision

Courthouse
GenBioPro asks court to prevent FDA from taking enforcement action against its generic mifepristone • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from US FDA

More from Agency Leadership